Skip to content
10-Q

Quarterly Report

CORCEPT THERAPEUTICS INC CORT

0001628280-25-048841

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 23, 2025 105.19M sh
Shares Diluted Q3 2025 · Sep 30, 2025 119.44M sh
Shares Diluted Q3 2025 · Sep 30, 2025 119.98M sh
Shares Diluted Q3 2025 · Sep 30, 2024 113.72M sh
Shares Diluted Q3 2025 · Sep 30, 2024 111.57M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $172.92M
Stock Repurchased Q3 2025 · Sep 30, 2024 $15.66M
Capex Q3 2025 · Sep 30, 2025 $161K
Capex Q3 2025 · Sep 30, 2024 $2.05M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $103.55M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 $138.24M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $125.14M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $127.67M
Stockholders Equity Q3 2025 · Sep 30, 2025 $631.9M
Stockholders Equity Q3 2025 · Jun 30, 2025 $635.79M
Stockholders Equity Q3 2025 · Mar 31, 2025 $683.29M
Stockholders Equity Q3 2025 · Dec 31, 2024 $679.59M
Stockholders Equity Q3 2025 · Sep 30, 2024 $638.84M
Stockholders Equity Q3 2025 · Jun 30, 2024 $596.24M
Stockholders Equity Q3 2025 · Mar 31, 2024 $547.86M
Stockholders Equity Q3 2025 · Dec 31, 2023 $506.71M
Current Liabilities Q3 2025 · Sep 30, 2025 $172.27M
Current Liabilities Q3 2025 · Dec 31, 2024 $140.77M
Total Liabilities Q3 2025 · Sep 30, 2025 $191.71M
Total Liabilities Q3 2025 · Dec 31, 2024 $160.96M
Current Assets Q3 2025 · Sep 30, 2025 $541.13M
Current Assets Q3 2025 · Dec 31, 2024 $471.6M
Total Assets Q3 2025 · Sep 30, 2025 $823.61M
Total Assets Q3 2025 · Dec 31, 2024 $840.55M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.16
Eps Diluted Q3 2025 · Sep 30, 2025 $0.62
Eps Diluted Q3 2025 · Sep 30, 2024 $0.41
Eps Diluted Q3 2025 · Sep 30, 2024 $0.98
Eps Basic Q3 2025 · Sep 30, 2025 $0.19
Eps Basic Q3 2025 · Sep 30, 2025 $0.71
Eps Basic Q3 2025 · Sep 30, 2024 $0.45
Eps Basic Q3 2025 · Sep 30, 2024 $1.06
Sga Expense Q3 2025 · Sep 30, 2025 $123.98M
Sga Expense Q3 2025 · Sep 30, 2025 $318.49M
Sga Expense Q3 2025 · Sep 30, 2024 $73.75M
Sga Expense Q3 2025 · Sep 30, 2024 $196.95M
Rd Expense Q3 2025 · Sep 30, 2025 $68.85M
Rd Expense Q3 2025 · Sep 30, 2025 $190.05M
Rd Expense Q3 2025 · Sep 30, 2024 $59.34M
Rd Expense Q3 2025 · Sep 30, 2024 $176.59M
Net Income Q3 2025 · Sep 30, 2025 $19.67M
Net Income Q3 2025 · Sep 30, 2025 $75.36M
Net Income Q3 2025 · Jun 30, 2025 $35.15M
Net Income Q3 2025 · Mar 31, 2025 $20.55M
Net Income Q3 2025 · Sep 30, 2024 $47.21M
Net Income Q3 2025 · Sep 30, 2024 $110.46M
Net Income Q3 2025 · Jun 30, 2024 $35.49M
Net Income Q3 2025 · Mar 31, 2024 $27.76M
Operating Income Q3 2025 · Sep 30, 2025 $10.22M
Operating Income Q3 2025 · Sep 30, 2025 $40.31M
Operating Income Q3 2025 · Sep 30, 2024 $46.6M
Operating Income Q3 2025 · Sep 30, 2024 $111.69M
Revenue Q3 2025 · Sep 30, 2025 $207.64M
Revenue Q3 2025 · Sep 30, 2025 $559.28M
Revenue Q3 2025 · Sep 30, 2024 $182.55M
Revenue Q3 2025 · Sep 30, 2024 $493.15M